I stood up at the last shareholder meeting which was held in Sydney a few years ago and raised the point of that the company should focusing on Europe , China and India and Asia . We should not waste our time and money on America as they clearly were not ready to accept the technology.
In saying this management clearly dropped the ball in not providing oversite into the clinical studys in America .
- Forums
- ASX - By Stock
- RAP
- Ann: Increased Scheme Consideration from Pfizer
Ann: Increased Scheme Consideration from Pfizer, page-232
-
-
- There are more pages in this discussion • 146 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online